ExodusPoint Capital Management’s Albireo Pharma Inc ALBO Stock Holding History

ExodusPoint Capital Management’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-35,874	Closed	-$695K	–	2300
2022 Q3	$695K	Sell	35,874 -17,031	-32%	-$352K	0.01%	1253
2022 Q2	$1.05M	Buy	+52,905	New	+$1.4M	0.01%	1060
2022 Q1	–	Sell	-12,547	Closed	-$292K	–	2820
2021 Q4	$292K	Buy	+12,547	New	+$334K	﹤0.01%	1670
2021 Q3	–	Sell	-6,534	Closed	-$230K	–	2844
2021 Q2	$230K	Buy	+6,534	New	+$212K	﹤0.01%	1903
2020 Q4	–	Sell	-12,370	Closed	-$413K	–	2511
2020 Q3	$413K	Buy	+12,370	New	+$360K	0.01%	1118

Other funds holding ALBO

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

ExodusPoint Capital Management's ALBO Position: Q4 2022 in Review

ExodusPoint Capital Management sold out of Albireo Pharma Inc (ALBO) in Q4 2022, closing a stake of 35,874 shares — an estimated $695K sold.

ExodusPoint Capital Management first reported a position in ALBO in Q3 2020 and held it in 5 quarters. The position peaked at $1.05M in Q2 2022. 96 funds tracked by Wall St. Rank hold ALBO as of Q4 2022.

ExodusPoint Capital Management reported no remaining Albireo Pharma Inc position as of Q4 2022 after selling out during the quarter.
ExodusPoint Capital Management sold 35,874 Albireo Pharma Inc shares in Q4 2022, an estimated $695K.
ExodusPoint Capital Management first reported a position in Albireo Pharma Inc in Q3 2020 and held it in 5 quarters.
ExodusPoint Capital Management's Albireo Pharma Inc position peaked at $1.05M in Q2 2022.
96 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2022.

Based on ExodusPoint Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.